Genetic studies have indicated that susceptibility to rheumatoid arthritis (R.A) maps to the HLA-DP, locus of the major histocompatibility complex. Strong linkage disequilibrium between certain HLA-DQ genes and HLA-DP,. genes associated with RA, however, suggests that HLA-DQ molecules may also play a role in RA susceptibility. To examine the role of HLA-DQ molecules in arthritis, we generated transgenic mice expressing the DQA 1"0301 and DQB 1"0302 genes from an RA predisposing haplotype (DQ8/DR.4Dw4). The transgenes were introduced into mouse class II-deficient H-2Ab ~ mice, and their susceptibility to experimental collagen-induced arthritis was evaluated. The HLA-DQ8+,H-2Ab ~ mice displayed good expression of the DQ8 molecule, while no surface expression of endogenous murine class II molecules could be detected. The DQ8 molecule also induced the selection of CD4 + T cells expressing a normal repertoire of V~ T cell receptors. Immunization of HLA-DQ8+,H-2Ab ~ mice with bovine type II collagen (CII) induced a strong antibody response that was crossreactive to homologous mouse CII. Also, in vitro proliferative responses against bovine CII, which were blocked in the presence of an antibody specific for HLA-DQ and mouse CD4, were detected. Finally, a severe polyarthritis developed in a majority of HLA-DQ8+,H-2Ab ~ mice, which was indistinguishable from the disease observed in arthritis susceptible B10.T(6R) (H-2Aq) controls. In contrast, HLA-DQ8-,H-2Ab ~ fullsibs did not generate CII antibody and were completely resistant to arthritis. Therefore, these results strongly suggest that HLA-DQ8 molecules contribute to genetic susceptibility to arthritis and also estabhsh a novel animal model for the study of human arthritis.
I
t is widely accepted that a strong genetic component contributes to the susceptibility or resistance to certain human autoimmune diseases (1) . Attempts to identify the particular genes involved in these disorders has been an area of major focus for many laboratories, and inroads have been clearly made. Among the numerous genes studied, one group that has garnered much attention are the genes encoding the class I and class II molecules of the HLA complex. Located on the short arm of chromosome 6, the primary function of HLA class I and II molecules is to bind and present processed antigenic peptides to T cells bearing receptors specific for the peptide-HLA complex. This presentation event plays a pivotal role in shaping the cellular immune repertoire and dictating the nature and scope of the immune response against a given antigen (2).
A role for HLA molecules in the etiology of autoimmune disease derives from genetic studies showing a clear association between the presence or absence of certain HLA class I or II alleles, as well as increased or decreased susceptibility to a particular autoimmune disorder. A disease with a strong autoimmune foundation and HLA class II association is rheumatoid arthritis (RA) 1. In Caucasians, genetic studies initially showed a high prevalence of the HLA-DR4Dw4 subtype among RA patients (3). Work using different ethnic groups, however, has implicated other Drs. Nabozny and Baisch made equal contributions to this study.
1Abbreviations used in this paper: CIA, collagen-induced arthritis; CII, type II collagen; RA, rheumatoid arthritis.
HLA-DR alleles in RA susceptibility. Subsequent analysis of the HLA-DR alleles associated with RA revealed that a large proportion of RA patients who express the Dw1, Dw4, Dw14, Dw15, or Dw16 haplotype bear a similar amino acid sequence within the 67-74 region of the HLA.DR [31 molecule (4, 5) . This similarity prompted investigators to put forth the "shared epitope" hypothesis for RA susceptibility (6) . The hypothesis states that a critical element in conferring an increased risk for RA susceptibility is possession of this common epitope within the HLA-DR[31 molecule. Whether strictly accurate or not, this hypothesis has had a tremendous influence in accelerating progress toward the molecular definition of RA susceptibility. However, the functional role for the "shared epitope" in RA remains obscure.
In general, HLA genes are inherited as a haplotype with a low recombination frequency between loci (7). Also, linkage disequilibrium between certain DQB genes and particular HLA-DR genes have revealed, for some disorders, a much stronger association at the DQ than DR locus. For instance, a strong association of HLA-DQ8 and DQ6 with susceptibility and protection, respectively, in type I diabetes has been demonstrated (8, 9) . Also, HLA-DQ polymorphisms have been shown to play a role in influencing autoantibody levels in primary Sjogren's syndrome (10) and myasthenia gravis (11) . Most recently, Welsh et al. (12) demonstrated an association between susceptibility to the disease allopecia areata and HLA-DQ8. In Caucasoids, the DQB0301 (DQ7) allele has been shown to be associated with a majority of HLA-DR4 alleles (6), while DQB0302 (DQ8) is in linkage disequilibrium with DR4 among the Asian population (13) . More importantly, data exists showing an increased frequency of a particular DQ allele, such as DQ7, in RA patients (14, 15) . Also, an interesting study analyzing Indian patients with RA showed that 100% of the patients possessed the DQ8 allele versus 33.3% in normal subjects (13) . On balance, these data support a role for HLA-DQ alleles in genetic predisposition to RA.
To better understand the role of HLA molecules in autoimmune disease, researchers have developed transgenic animals expressing disease-associated HLA gene products. Success using this approach was illustrated by the development of a transgenic rat model for HLA-B27-associated spondyloarthropathy (16) . Initial studies with transgenic mice expressing human class II genes demonstrated that the HLA class II molecules are functional as shown by the intrathymic deletion of T lymphocytes bearing certain V~ T cell receptors (17, 18) . However, the consistent generation of human class II-restricted immune responses in these transgenic mice has been limited (19, 20) . A possible reason for such poor responsiveness may be an inefficient interaction between the mouse CD4 coreceptor and the human class II molecule (21) . Recent attempts to circumvent this problem have led to the generation of enhanced human class II-restricted immune responses. For instance, Woods et al. (22) constructed a human-mouse chimaeric HLA-DR4/H-2E transgene containing the mouse CD4-binding domain, while Fugger et al. (23) recovered human class IIrestricted responses in HLA-DR4 transgenic mice coexpressing the human CD4 molecule. Similarly, Yeung et al. (24) showed that expression of the human CD4 and HLA-DQ6 molecules in mice bearing disrupted murine CD4 and CD8 genes reconstituted the human class II-restricted limb of the immune system. In all cases, however, the ability of these mice to mount a protective or pathologic response against a known pathogen or autoantigen is unknown. Likewise, deciphering the functional role of HLA molecules in these animals may prove problematic given the dominant expression of endogenous mouse class II molecules.
An alternative approach to generate human class IIrestricted responses in mice is to express the HLA class II transgene in animals rendered deficient for mouse class II expression through gene targeting. Expression of the human class II molecule in the absence of mouse class II gene products should, in theory, lead to the preferential development of a population of human class II-restricted T cells. With this hypothesis in mind, therefore, we introduced a transgene encoding the c~ and j3 chains of the HLA-DQBI*0302, DQAI*0301 molecule (HLA-DQS) into mouse class II-deficient H-2Ab ~ mice. The HLA-DQ8 molecule was chosen because of its reported association with various autoimmune disorders, such as RA (13) . Given the presence of local immune reactivity against type II collagen (CII) within inflamed synovial tissue of some RA patients (25) , we evaluated the susceptibility of HLA-DQ8+,H-2Ab ~ mice to the experimental disease collageninduced arthritis (CIA), a model that bears many similarities to human RA (26) . We report here that expression of the HLA-DQ8 molecule in murine class lI-deficient H-2Ab {} mice leads to the selection and restoration of a peripheral CD4 + T cell compartment. Moreover, immunization of HLA-DQS+,H-2Ab ~ mice with CII induced a vigorous anti-CII response that culminated in a severe inflammatory polyarthritis in a majority of the animals. These studies are the first report demonstrating the induction of a pathogenic immune response in human class II transgenic mice, and they establish a unique animal disease model to dissect the role of HLA class II molecules in human polyarthritis.
Materials and Methods
Mice. All mice used in this study were bred and maintained in the pathogen-free Immunogenetics Mouse Colony of the Mayo Clinic. Generation ofB10.M-DQ8 transgenic mice was achieved as follows: briefly, cosmids H11A and X10A, which contain the DQA*0301 and DQB*0302 genes, respectively, were provided by Dr. Jack Strominger (Harvard University, Cambridge, MA). Clone H11A is a 30-kb DNA fragment containing the DQA*0301 gene and the DQB*0302 gene with a truncated promoter. Clone X10A is a 38-kb DNA fragment containing in the center, DQB*0302 gene (27) . The cosmid inserts were released by SalI digestion, purified, and microinjected into (CBA/J • B10.M)F 2 embryos, as previously described (28) . Transgene-positive founders were identified by Southern blot analysis of tail DNA and subsequently mated to B10.M mice. The HLA-DQ8 transgenes were introduced into H-2Ab ~ mice as described in Fig. 1 (37) . After a 30-min incubation, the cells were washed then incubated with FITC-conjugated Fab' 2 fragments specific for either mouse or rat IgG or rat IgM (Accurate Chemical). After 30 min, the cells were washed and then incubated with a 1:1 mixture of PE-and red 613-conjugated mAb specific for mouse CD4 and CD8, respectively (GIBCO BILL, Gaithersburg, MD). Finally, the samples were washed and fixed with 1% formalin. Both single-and three-color fluorescent analysis were performed using a FACS | vantage flow cytometer (Becton Dickinson & Co., Mountain View, CA).
Induction of CIA.
Highly purified native bovine and mouse CII were isolated as described elsewhere (38) . Lyophilized bovine ClI was dissolved overnight at 4~ in 0.01 N acetic acid then emulsified at a 1:1 ratio with CFA (Mycobacterium tuberculosis strain H37 ILa; Difco Laboratories, Detroit, MI). The animals were subsequently immunized with 100 bel (100 mg bovine CII) of the emulsion at the tail base. 28 d later, the animals received a booster injection of 100 beg bovine CII emulsified in IFA. The mice were carefully monitored three to four times per week for the onset and progression of CIA from the beginning of the experiment until its termination at 12 wk after immunization. The severity of arthritis was evaluated as previously described (39) based on a grading system for each paw as follows: 1 = redness or swelling in paw or toes; 2 = severe swelling and/or joint deformity; 3 = joint ankylosis. The score per paw was summed to give a maximal possible score of 12 per animal. The mean CIA score per group was determined using arthritic animals only.
Anti-CII ELISA. The level of IgG antibody reactive against bovine and mouse CII was determined using a highly sensitive ELISA technique (40) . Briefly, day 35 sera from bovine CII-immunized mice was diluted in PBS containing 0.05% Tween 20 and 0.2 M NaC1 (PNT). Microtiter wells were coated with either bovine or mouse ClI dissolved in KPO 4 buffer, pH 7.6, at 300 ml per well (20 beg/ml of ClI) overnight at 4~ After washing with PNT, the wells were blocked with 1% BSA in PNT. Duplicate serial fourfold dilutions of sera (1:100 to 1:6,400) were then added to the wells and incubated at 4~ overnight. The wells were washed, incubated with a peroxidase-conjugated goat antimouse IgG (Organon Teknika Corp., West Chester, PA), and the color was developed using O-phenylenediamine. The amount of total IgG anti-CII antibody was calculated by comparing OD values with a high titer standard sera arbitrarily determined to contain 100 CII anitbody U/m] sera.
In Vitro LNC Proliferation. Lyophilized bovine CII was dissolved in 0.1 N acetic acid overnight at a concentration of 2 rag/ ml and then emulsified 1:1 with CFA. Mice received an intradermal injection of 100 bel of cold emulsion at the tail base and 50 ILl in each hind footpad for a total of 200 beg bovine CII per mouse. 10 d later, the animals were killed, and the draining LNC were isolated and suspended to a concentration of 107/ml in ILPMI 1640 medium (GIBCO BILL) supplemented with 5% heat-inactivated horse serum, 25 mM Hepes buffer, 2 mM glutamine, 100 U/ml penicillin, and 100 beg/ml streptomycin. 100 bel of the cell suspension, containing 106 cells, were added per flat-bottom microtiter wells (Coming Glassware, Coming, NY), and they were subsequently challenged with 100 bel media alone or 50 beg/ml heat-denatured ( Histologic Evaluation. Mice were killed at the end of the experiment and histological sections of the hind limbs were prepared by the Pathology Department of the Mayo Clinic. Limbs were dissected, and the joints were decalcified for 3-4 d and then embedded in paraffin blocks. Sections that were "-~6 I.Lm thick were cut for each joint at differing intervals, mounted, and stained with hematoxilyn and eosin before analysis.
Statistical Analysis. Statistical differences in the mean arthritic severity and mean day of CIA onset between groups was determined using the nonparametric Mann-Whitney U test.
Results

Introduction and Expression of the HLA-DQ8 Molecule in H-2Ab ~ Mice.
In an effort to understand the role of HLA class II molecules in R.A, we introduced the RA-associated HLA-DQBI*0302 and DQAI*0301 genes (HLA-DQS) into mouse class II-deficient H-2Ab ~ mice. Fig. 1 illustrates the strategy to derive the HLA-DQ8+,H-2Ab ~ line. Briefly, B10.M (H-2 f) mice bearing a transgene encoding the DQ0301 (x and DQ0302 [3 chain genes of the HLA-DQ8 molecule were mated with H-2Ab ~ mice (41) . The offspring were screened for HLA-DQ8 expression by flow cytometric analysis of PBL using the HLA-DQ specific mAb IVD12. The HLA-DQ8+,H-2Ab f/~ progeny were intercrossed, and segregation of the H-2Ab ~ and H-2Ab f gene was monitored via fluorescent analysis using the H-2A C specific mAb 3F-12 and the H-2Ab-specific mAb AF6-120. The offspring that typed as HLA-DQ8+,H-2Ab ~176 and HLA-DQ8-,H-2Ab ~176 were selected and intercrossed 
Selection of Peripheral CD4 + T Cells in HLA-DQw8+, -H-2Ab~
A hallmark feature of class II-deficient H-2Ab ~ mice is a paucity of peripheral CD4 + T cells. In general, H-2Ab ~ animals contain <5% CD4 + cells within the lymph nodes, and the majority of these cells express the CD44 (Pgp-1) antigen (41) . To determine if expression of the human HLA-DQ8 molecule in H-2Ab ~ mice induces the selection of CD4 + T cells, LNC from HLA-DQ8+,H2Ab ~ and negative littermate HLA-DQ8-,H-2Ab ~ mice were analyzed for the expression of CD4 and CD44 molecules. As a comparative control, mouse class II~sutiqcient B10.T(6R) mice, which bear the collagen arthritis susceptible H-2Aq molecule (39), were also studied. Table 1 shows that HLA-DQ8+,H-2Ab ~ mice displayed a threefold increase in the level of CD4 + LNC versus HLA-DQ8-,H2Ab ~ animals. Moreover, the frequency of double-positive CD4/CD44 (Pgp-1) cells in the HLA-DQ8+,H-2Ab ~ line closely resembled mouse class II~uflicient B10.T(6R) mice. Similar to previous reports (41) , "~ of the CD4 + cells in HLA-DQ8-,H-2Ab ~ mice expressed the CD44 molecule. Single positive HLA-DQ8~ or HLA-DQ8~ transgenic mice did not display an increase in CD4 + LNC, thereby illustrating the importance of appropriate HLA-DQ8 o~ and [3 pairing in the restoration of the CD4 + T cell compartment. Analysis of V~ TC1K expression within the CD4 + population showed that HLA-DQ8 § ~ mice expressed a variety of V~ TC1Ks. In addition, distinct differences in the level of some CD4+/V~ TC1K + cells, such as Vf35 and V~8.2, was detected between HLA-DQ8+,H2Ab ~ mice and transgene-negative littermates (Table 1) . On balance, these data suggest that expression of the HLA-DQ8 molecule in H-2Ab ~ mice induces the selection of CD4+,V~TCR + cells , which are distinct from the small population of CD4 + lymphocytes normally present in class II-deficient H-2Ab ~ mice.
Production of CII Antibody in HLA-DQ8+,H-2Ab ~ Mice. Typically, murine CIA is induced in susceptible strains of mice bearing the H-2 q or H-2 r haplotype after immunization with ClI in CFA (39, 43) . Both humoral and cellular immune responses against the CII molecule is essential for the development of severe chronic arthritis (44) and induction of CIA is critically dependent upon the presence of CII-specific CD4 +, TC1K o~[3 + T cells (45, 46) .
Given the putative association of the HLA-DQ8 allele in certain RA populations (13) , it was possible that the HLA-DQ8+,H-2Ab ~ mice possessed the potential to mount a pathogenic immune response against CII, a molecule implicated in [CA (25, 47) . Therefore, HLA-DQ8+,H-2Ab ~ animals, along with transgene-negative littermates, positive control B10.T(6R) and negative control H-2Ab ~ mice, were immunized with bovine CII in CFA and monitored for the generation of a CII-specific antibody. Analysis of sera 35 d after immunization by ELISA revealed that HLA-DQ8+,H-2Ab ~ mice mounted a strong IgG antibody response against bovine CII (Fig. 3) . The level of bovine CII antibody was comparable to arthritis-susceptible B10.T(61K) controls, and no CII reactivity was detected in sera from HLA-DQ8-,H-2Ab ~ littermates or H-2Ab ~ animals. Moreover, HLA-DQ8+,H-2Ab ~ sera was highly cross-reactive against mouse CII. Like the reactivity against bovine CII, the level of mouse CII-reactive antibody was similar to B10.T(61K) sera, and the extent of cross-reactivity in both strains was >50%. Although many mouse strains of various H-2 haplotypes can mount antibody responses against a heterologous CII species, strong reactivity against homologous mouse CII is limited to strains that bear a CIA-susceptible H-2 haplotype (48). Thus, the generation of mouse CII reactive antibody in HLA-DQ8+,H-2Ab ~ mice suggested that these animals may have the potential to develop collagen arthritis.
In Vitro Proliferative Response Of HLA-DQ8+,H-2Ab ~ LNC against Bovine CII. To further explore the immune response of HLA-DQ8+,H-2Ab ~ mice against bovine CII, in vitro LNC prolferative responses were assessed. Fig. 4 A shows that LNC from bovine CII-immunized HLA-DQ8 +,-H-2Ab ~ mice mounted a detectable proliferative response against bovine CI! in vitro (stimulation index >2.5), which is comparable to control B10.T(61K) mice. Also, addition of mAb specific for the human HLA-DQ or mouse CD4 molecules inhibited the anti-bovine CII response by >90% ( Fig. 4 B) . No inhibition was observed in cultures containing mAb specific for mouse H-2A~ b, H-2Er3 b, or CD8. These data indicate that CD4 § T cells recognize and proliferate to bovine CII presented by the HLA-DQ8 molecule.
Development of Arthritis in HLA-DQ8+,H-2Ab ~ Mice.
To determine if the immune response against bovine CII was arthritogenic, bovine CII-immunized HLA-DQ8+,H-2Ab ~ mice, HLA-DQ8-,H-2Ab ~ littermates, B10.T(6R) animals, and H-2Ab ~ mice were monitored for the onset and development of CIA. As shown in Table 2 , experiment 1, HLA-DQ8+,H-2Ab ~ mice were highly susceptible to CIA. Among the 18 animals tested, 12 developed a noticeable arthritis in ~5 wk after immunization which progressed to severe arthritis and persisted until the termination of the experiment. In general, both HLA-DQ8+,H-2Ab ~ and B10.T(6R) animals developed severe inflammation, swelling, and joint deformity in afflicted limbs (Fig. 5, B and C) . Histologic examination of arthritic hind limbs showed that the nature of the inflammatory infiltrate was similar in both strains; a marked synovitis consisting of synovial cell hyperplasia, infiltration of mononuclear cells, and erosion of articular cartilage and subchondral bone was observed (Fig. 5 , E and H versus F and /). Transgene-negative HLA-DQ8-,H-2Ab ~ littermates showed no signs of clinical arthritis and histologic evidence of synovial inflammation was not detected (Fig. 5, A, D , and G). Serum analysis revealed that both arthritic and nonarthritic HLA-DQ8+,H-2Ab ~ and B10.T(6R) mice possessed the bovine CII~pecific IgG antibody that was cross-reactive against mouse CII. Also, no significant correlation in the level of CII antibody and the development or severity of CIA was detected in either the HLA-DQS+,H-2Ab ~ or B10.T(6R) strains (data not shown). To confirm our observations, a second HLA-DQ8+,H2Ab ~ line that expresses the HLA-DQ8 molecule on "-'15% of PBL were immunized with bovine CI1 and monitored for C1A. Once again, a majority of HLA-DQ8+,H-2Ab ~ mice developed CIA (Table 2 , experiment 2). Interestingly, the onset of clinical arthritis was significantly earlier in this HLA-DQ8+,H-2Ab ~ line compared to B10.T(6R) mice. Likewise, the severity of CIA was significantly greater in arthritic HLA-DQ8+,H-2Ab ~ animals. Transgene-negative HLA-DQ8-,H-2Ab ~ littermates did not develop CIA, and antibody against bovine CII was not detected (data not shown). Therefore, these findings demonstrate that expression of the DR4-1inked HLA-DQ8 molecule in class II- 
Discussion
The data presented here comprise the first report demonstrating the induction of a pathogenic autoimmune response in mice expressing a human MHC class II molecule. By introducing an HLA-DQ8 transgene into murine class II-deficient H-2Ab ~ mice, we observed that this human class II molecule induced selection ofa CD4 + T cell population and conferred susceptibility to the R_A-like disease CIA. Our findings establish a novel animal model to study autoimmune arthritis, as well as a means to functionally address a possible role for HLA-DQ molecules in genetic predisposition to KA.
Previous studies suggested that the inability of the mouse CD4 coreceptor to interact efficiently with human class II would limit the experimental usefulness of HLA class II transgenic mice. The results in this study clearly demonstrate that mouse CD4 coreceptors can sufficiently interact with the HLA-DQ molecule in the absence of endogenous mouse class II. Thus, the interaction between mouse CD4 and human class II appears to be affinity oriented, and the absence of mouse class II molecules within the thymus of HLA-DQ8 +, H-2Ab ~ mice successfully forces the selection of HLA-DQ8 restricted CD4 § cells. Although the work of Vignali et al. The level of peripheral CD4 + T cells in HLA-DQS+,H2Ab ~ mice was lower than mouse class II-sufficient, CIAsusceptible B10.T(6R) mice. The frequency of CD4 § cells in HLA-DQ8+,H-2Ab ~ animals, however, was threefold higher than HLA-DQ8-,H-2Ab ~ littermates. Moreover, the CD4 + populations were distinct between the two lines based on expression of the CD44 molecule. When immunized with bovine CII, strong antibody responses against CII were measured in HLA-DQ8 § ~ mice. In addition, in vitro proliferative responses against bovine CII that were effectively inhibited by mAbs specific for HLA-DQ and mouse CD4 were detected. These results strongly suggest that the response against bovine CII is mediated by CD4 + T cells restricted by the HLA-DQ8 molecule. Of p a r a m o u n t i m p o r t a n c e was the finding that the a n t i -C I I response was arthritogenic. A severe i n f l a m m a t o r y poly- HLA-DQ8+,H-2Ab ~ mice are similar to those responsible for prototypical CIA. Also, the susceptibility of HLA-DQ8+,H-2Ab ~ mice to CIA is reproducible as illustrated by the development of arthritis in a second group of HLA-DQ8+,H-2Ab ~ animals, which expressed a lower level of HLA-DQ8 + cells in PBL. Interestingly, this line of mice developed an accelerated and more severe CIA versus B10.T(6R) controls. Whether this difference was merely an exceptional observation or a distinct characteristic of this particular HLA-DQ8+,H-2Ab ~ line requires further investigation. Nonetheless, the data clearly show that expression of the HLA-DQ8 molecule confers susceptibility to CIA. Finally, preliminary studies indicate that polymorphisms within the HLA-DQ molecule dictates susceptibility to CIA; bovine CII immunized HLA-DQ6+,H-2Ab ~ mice mount weak responses to ClI and do not develop ClA (Nabozny, G.H., and C.S. David, unpublished observations). Given the lack of association between HLA-DQ6 and human RA, such data is of interest.
To date, identification of the antigens and/or agents responsible for the manifestations in RA have not been unequivocally demonstrated. Candidate antigens include tissue proteoglycans (51), heat shock proteins, (52) as well as CII (53) . The relative role for immunity against CII in RA pathogenesis remains controversial; however, extant in the literature are reports clearly showing the presence of ClI reactive T cells (54) , B cells (25, 47) , and antibody (53) within inflammed synovium of RA patients. Such anti-CII immunity is not observed in patients with other inflammatory joint diseases such as psoriatic arthritis (25) . In addition, CII-reactive antibody from RA patients can passively induce an inflammatory arthritis in naive mice, thus illustrating its arthritogenic potential (55) . Our finding that the HLA-DQ8 molecule can restrict an arthritogenic CII response is intriguing and, at the very least, points to a possible role for CII as an antigenic target in RA. Clearly, identification of the precise regions on CII responsible for ClA in the HLA-DQ8+,H-2Ab ~ strain may provide insight concerning the contribution of ClI immunity in arthritis.
The successful induction of arthritis in mice expressing an HLA-DQ molecule raises questions regarding the role of HLA-DQ alleles in human arthritis. Considered sine qua non for RA susceptibility, a majority of recent research efforts have focused upon understanding the significance of the HLA-DR-associated "shared epitope" in RA. In contrast, less extensive studies have dealt with HLA-DQ associations in this disease. Preliminary studies using HLA-DR4 human CD4 double-transgenic mice suggests that these animals can be induced to mount HLA-DR4--restricted responses against CII, but fail to develop arthritis (56) . Recently, our laboratory has hypothesized a more prominent role for HLA-DQ alleles in RA (57) . The generation of CIA in the HLA-DQ8+,H-2Ab ~ transgenic mice provides a useful tool to test such an hypothesis. It is possible that our findings may serve as a model for a subset of HLADQw8 + RA patients with strong CII immunity or as a broader model for RA in general. Regardless, our results suggest that a more thorough examination regarding a potential contribution for HLA-DQ alleles in RA is warranted. Quite possibly, an extended haplotype consisting of a particular HLA-DQ and HLA-DR molecule may ultimately be shown to be a necessary factor for the induction and progression of this disease.
The potential research opportunities available via the use ofHLA-DQ8+,H-2Ab ~ mice are exciting. The use of these animals as a novel model to study autoimmune arthritis is obvious. In addition to ClI, other potential autoantigens and arthritogens such as bacterial and viral superantigens, heat shock proteins, and extracellular matrix proteins can be tested in these mice. Also, this strain provides a useful vehicle to assess the therapeutic efficacy of human HLA class II-blocking agents in the modulation of a pathogenic in vivo immune response. Likewise, identification of TCR usage against ClI in HLA-DQ8+,H-2Ab ~ mice may open the door towards identifying homologous human TCRs important in RA. Finally, introduction of additional HLA-DQ or HLA-DR molecules in these mice will provide an opportunity to study the interactions and influences of multiple human class II alleles on a defined immune response. Hopefully, our findings have laid the foundation for an exciting and fruitful new era in human autoimmune disease research.
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